Clinical Trial: The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study

Brief Summary: The purpose of this study is to determine if the addition of the medication, deferasirox, to standard antifungal therapy for the infection, mucormycosis, is safe and effective